Clarithromycin
Ref 0049B30, 0049B10, 0049B05
Clarithromycin (0049B30) is an in vitro diagnostic device (EU IVDR Class B; EMDN category mic systems - dilution methods (incl. e-test)) made by BioMaxima Spółka Akcyjna, registered in EUDAMED on 18 Sep 2025 (Basic UDI-DI 59026439BBMCLRHZ), active as of 25 Oct 2026.
Active
CE IVDR
Valid until
No date given
FDA recalls
Not applicable
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR | Number59026439BBMCLRHZ | Date18 Sep 2025 | StatusActive |
Official records
- EUDAMED public site 59026439BBMCLRHZ
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDR Active
Specification
- Device name
- MIC test CLARITHROMYCIN
- Model / reference
- 0049B30, 0049B10, 0049B05
- Primary DI / UDI-DI
- 05902643975491, 05902643972995, 05902643970496
- Basic UDI-DI
- 59026439BBMCLRHZ
- EMDN code
- W0104080501 Mic systems - dilution methods (incl. e-test)
- Device class
- Class B
- EU registration type
- Standard device
- EU market of registration
- Poland
Manufacturer details
- EUDAMED SRN
- PL-MF-000039473
Similar devices in this category
Other devices filed under MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST).
- Liofilchem MTS (MIC Test Strip) 921140 by Liofilchem, Inc.
- ETEST® Cephalothin (CE) by BIOMERIEUX SA
- Liofilchem MTS (MIC Test Strip) 920760 by Liofilchem, Inc.
- ETEST® Quinupristin/Dalfopristin (QDA) by BIOMERIEUX SA
- ETEST Delafloxacin (DFX) (0.002-32 µg/mL) by Biomerieux S.A.
- ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) by Biomerieux S.A.